Solara Active Pharma Sciences Share Price
Start SIP in Solara Active Pharma Sciences
Start SIPSolara Active Pharma Sciences Performance
Day Range
- Low 740
- High 773
52 Week Range
- Low 264
- High 814
- Open Price760
- Previous Close760
- Volume29418
Solara Active Pharma Sciences Investment Rating
-
Master Rating:
-
Solara Active Pharma Scis has an operating revenue of Rs. 1,336.89 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of -38% needs improvement, ROE of -60% is poor and needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 62% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 363 | 299 | 249 | 425 | 352 | 381 |
| Operating Expenses Qtr Cr | 321 | 290 | 410 | 388 | 333 | 329 |
| Operating Profit Qtr Cr | 42 | 10 | -162 | 38 | 19 | 52 |
| Depreciation Qtr Cr | 25 | 25 | 26 | 26 | 26 | 26 |
| Interest Qtr Cr | 31 | 31 | 25 | 24 | 26 | 22 |
| Tax Qtr Cr | 0 | 89 | 0 | 0 | -10 | 2 |
| Net Profit Qtr Cr | -12 | -256 | -275 | -15 | -20 | 6 |
Solara Active Pharma Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹730.04
- 50 Day
- ₹666.05
- 100 Day
- ₹591.66
- 200 Day
- ₹512.34
- 20 Day
- ₹735.56
- 50 Day
- ₹663.04
- 100 Day
- ₹567.54
- 200 Day
- ₹468.71
Solara Active Pharma Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 763.97 |
| Second Resistance | 784.98 |
| Third Resistance | 796.97 |
| RSI | 57.05 |
| MFI | 76.54 |
| MACD Single Line | 34.63 |
| MACD | 32.07 |
| Support | |
|---|---|
| First Support | 730.97 |
| Second Support | 718.98 |
| Third Supoort | 697.97 |
Solara Active Pharma Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 36,121 | 3,612,100 | 100 |
| Week | 75,265 | 7,526,520 | 100 |
| 1 Month | 99,812 | 9,981,218 | 100 |
| 6 Month | 350,086 | 13,096,716 | 37.41 |
Solara Active Pharma Sciences Result Highlights
Solara Active Pharma Sciences Synopsis
NSE-Medical-Diversified
Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1288.92 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2024. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.| Market Cap | 3,054 |
| Sales | 1,337 |
| Shares in Float | 2.53 |
| No of funds | 50 |
| Yield |
| Book Value | 3.17 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 11 |
| Alpha | 0.23 |
| Beta | 1.28 |
Solara Active Pharma Sciences Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 37.27% | 30.49% | 30.49% | 37.19% |
| Mutual Funds | 1.28% | 1.71% | 1.71% | 1.75% |
| Foreign Portfolio Investors | 14% | 15.8% | 16.62% | 17.86% |
| Financial Institutions/ Banks | 0.04% | 0.04% | ||
| Individual Investors | 19.61% | 20.15% | 20.96% | 19.84% |
| Others | 27.84% | 31.81% | 30.22% | 23.32% |
Solara Active Pharma Sciences Management
| Name | Designation |
|---|---|
| Mr. R Ramakrishnan | Chairman & Ind.Director |
| Mr. Poorvank Purohit | Managing Director & CEO |
| Mr. Mohan Muthunarayanan | COO & Executive Director |
| Mr. Manish Gupta | Non Executive Director |
| Mr. Kartheek Chintalapati Raju | Non Executive Director |
| Mr. Arun Kumar | Non Executive Director |
| Dr. Kausalya Santhanam | Independent Director |
| Mr. Rajiv Vijay Nabar | Independent Director |
| Mr. Rajendra Kumar Srivastava | Independent Director |
Solara Active Pharma Sciences Forecast
Price Estimates
Solara Active Pharma Sciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-22 | Quarterly Results | |
| 2024-05-29 | Audited Results | |
| 2024-05-09 | To consider Fund Raising | |
| 2024-02-14 | Quarterly Results | |
| 2023-11-14 | Quarterly Results |
Solara Active Pharma Sciences FAQs
What is Share Price of Solara Active Pharma Sciences ?
Solara Active Pharma Sciences share price is ₹742 As on 18 September, 2024 | 02:25
What is the Market Cap of Solara Active Pharma Sciences ?
The Market Cap of Solara Active Pharma Sciences is ₹2987 Cr As on 18 September, 2024 | 02:25
What is the P/E ratio of Solara Active Pharma Sciences ?
The P/E ratio of Solara Active Pharma Sciences is -5.3 As on 18 September, 2024 | 02:25
What is the PB ratio of Solara Active Pharma Sciences ?
The PB ratio of Solara Active Pharma Sciences is 3.2 As on 18 September, 2024 | 02:25